AGAPE ATP CORPORATION Finance Lease, Right-of-Use Asset, Amortization
AGAPE ATP CORPORATION (ATPC) reported Finance Lease, Right-of-Use Asset, Amortization of $6.72 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:FinanceLeaseRightOfUseAssetAmortization · last filed 2026-08-14
- AGAPE ATP CORPORATION finance lease, right-of-use asset, amortization for the quarter ending 2026-06-30 was $6.72K, a 6.87% increase year-over-year.
- AGAPE ATP CORPORATION finance lease, right-of-use asset, amortization for the quarter ending 2026-03-31 was $11.91K, a 11.96% increase year-over-year.
- AGAPE ATP CORPORATION finance lease, right-of-use asset, amortization for the quarter ending 2025-12-31 was $11.38K, a 8.51% increase year-over-year.
- AGAPE ATP CORPORATION finance lease, right-of-use asset, amortization for the quarter ending 2025-09-30 was $11.12K, a 6.49% decline year-over-year.
- AGAPE ATP CORPORATION finance lease, right-of-use asset, amortization for fiscal 2024 was $29.45K, a 124.87% increase from fiscal 2023.
- AGAPE ATP CORPORATION finance lease, right-of-use asset, amortization for fiscal 2023 was $13.09K.
| Period end | Finance Lease, Right-of-Use Asset, Amortization 3 month | Finance Lease, Right-of-Use Asset, Amortization 3 month as first filed | Finance Lease, Right-of-Use Asset, Amortization 6 month | Finance Lease, Right-of-Use Asset, Amortization 6 month as first filed | Finance Lease, Right-of-Use Asset, Amortization 9 month | Finance Lease, Right-of-Use Asset, Amortization 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6.72K 10-Q · filed 2026-08-14 | $13.52K 10-Q · filed 2026-08-14 | $30.01K derived: sum of 3 quarters · filed 2026-08-14 | $41.13K derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2026-03-31 | $11.91K 10-Q · filed 2026-05-15 | $23.29K derived: sum of 2 quarters · filed 2026-05-15 | $34.41K derived: sum of 3 quarters · filed 2026-05-15 | $40.70K derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-12-31 | $11.38K derived: 10-Q 12 month − 10-Q 9 month · filed 2026-05-15 | $22.51K derived: sum of 2 quarters · filed 2026-05-15 | $28.79K derived: sum of 3 quarters · filed 2026-08-14 | $44.15K 10-Q · filed 2026-05-15 | ||
| 2025-09-30 | $11.12K 10-Q · filed 2025-11-13 | $17.41K derived: sum of 2 quarters · filed 2026-08-14 | $32.77K 10-Q · filed 2025-11-13 | $38.53K derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-06-30 | $6.29K 10-Q · filed 2026-08-14 | $11.01K 10-Q · filed 2025-08-13 | $12.36K 10-Q · filed 2026-08-14 | $21.64K 10-Q · filed 2025-08-13 | $27.41K derived: sum of 3 quarters · filed 2026-08-14 | $39.31K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $10.63K 10-Q · filed 2025-05-15 | $21.12K derived: sum of 2 quarters · filed 2026-04-13 | $33.02K derived: sum of 3 quarters · filed 2026-04-13 | $37.28K derived: sum of 4 quarters · filed 2026-04-13 | ||
| 2024-12-31 | $10.49K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-13 | $22.39K derived: sum of 2 quarters · filed 2026-04-13 | $26.65K derived: sum of 3 quarters · filed 2026-04-13 | $29.45K 10-K · filed 2026-04-13 | ||
| 2024-09-30 | $11.90K 10-Q · filed 2025-11-13 | $16.16K derived: sum of 2 quarters · filed 2025-11-13 | $18.96K 10-Q · filed 2025-11-13 | |||
| 2024-06-30 | $4.26K 10-Q · filed 2025-08-13 | $8.52K 10-Q · filed 2025-08-13 | ||||
| 2024-03-31 | $4.26K 10-Q · filed 2024-05-14 | |||||
| 2023-12-31 | $13.09K 10-K · filed 2025-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |